메뉴 건너뛰기




Volumn 6, Issue 1, 2002, Pages 37-41

Randomized, double-blind, placebo-controlled trial of oromucosal low-dose interferon following prednisone withdrawal for chronic hepatitis B infection in Filipino patients

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; LYMPHOBLAST INTERFERON; PREDNISONE; VIRUS DNA;

EID: 0036299046     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(02)90134-7     Document Type: Article
Times cited : (5)

References (11)
  • 1
    • 0033799182 scopus 로고    scopus 로고
    • Consensus statement on the prevention and management of hepatitis B and C in Asia-Pacific region
    • (2000) J Gastroenterol Hepatol , vol.15 , pp. 825-841
  • 11
    • 0026043814 scopus 로고
    • Absorption of cytokines via oropharyngeal associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon?
    • (1991) Clin Pharmacokinet , vol.21 , pp. 411-417
    • Bocci, V.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.